| Date Filed | Type | Description |
| 08/10/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 57,286 shares
@ $1.9986, valued at
$114.5k
Sold 2,714 shares
@ $2.02, valued at
$5.5k
Exercised 57,286 options to buy
@ $0.39, valued at
$22.3k
Exercised 2,714 options to buy
@ $0.3, valued at
$814.2 |
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 8,929 shares
@ $2.1, valued at
$18.8k
|
|
| 05/17/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 03/20/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 11,228 shares
@ $1.67, valued at
$18.8k
|
|
| 12/19/2022 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 8,424 shares
@ $1.5, valued at
$12.6k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2022 |
4
| Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $13.5022, valued at
$270k
Exercised 20,000 options to buy
@ $0.39, valued at
$7.8k
|
|
| 09/19/2022 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,294 shares
@ $2.62, valued at
$11.3k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.39, valued at
$15.6k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $19.4297, valued at
$194.3k
Sold 10,000 shares
@ $19.2021, valued at
$192k
Sold 10,000 shares
@ $19.9668, valued at
$199.7k
Exercised 10,000 options to buy
@ $3.72, valued at
$37.2k
Exercised 10,000 options to buy
@ $3.72, valued at
$37.2k
Exercised 10,000 options to buy
@ $3.72, valued at
$37.2k
|
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $21.08, valued at
$4.6M
|
|
| 01/24/2020 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 6,000 options to buy
@ $0.39, valued at
$2.3k
|
|
| 01/17/2019 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 9,000 options to buy
@ $0.39, valued at
$3.5k
|
|
| 01/02/2019 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 225,000 options to buy
@ $19.56, valued at
$4.4M
|
|
| 11/16/2018 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 4,985 shares
@ $39.8399, valued at
$198.6k
Sold 15 shares
@ $40.59, valued at
$608.9
Exercised 5,000 options to buy
@ $3.72, valued at
$18.6k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2018 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,835 shares
@ $65.7376, valued at
$186.4k
Sold 1,865 shares
@ $66.9158, valued at
$124.8k
Sold 300 shares
@ $67.95, valued at
$20.4k
Exercised 5,000 options to buy
@ $3.72, valued at
$18.6k
|
|
| 08/17/2018 |
4
| Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,699 shares
@ $55.3287, valued at
$149.3k
Sold 2,301 shares
@ $56.5171, valued at
$130k
Exercised 5,000 options to buy
@ $3.72, valued at
$18.6k
|
|
|